Emerging evidence suggests that some individuals develop nutritional deficiencies during treatment, whereas others experience biologically driven GLP-1 resistance.
Kanwal Fatima, PharmD, BCMAS
Advertisement
Kanwal Fatima, PharmD, BCMAS
📧 Email: fatimakanwal940@gmail.com
đź”— LinkedIn: linkedin.com/in/kanwal-fatima-2a4016202
Articles by Kanwal Fatima, PharmD, BCMAS
As biomedical research output continues to grow, so does the demand for professionals who can accurately interpret data and communicate it responsibly to diverse audiences.
Advertisement
Latest Updated Articles
Why Some Patients Do Not Respond to GLP-1 TherapiesJune 2nd 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
What Cemdisiran Could Mean for Myasthenia Gravis Treatment and Patient Safety
3
Celebrate the Path to MTM During American Pharmacists Month
4
Navigating the Shift From Cockcroft-Gault to eGFR for Drug Dosing
5